Skip to content

Attenuation of Neutrophil Extracellular Trap Formation in Lipopolysaccharide-Induced Acute Lung Injury Associated with Cinnamaldehyde.

Sep 2026 · Immunological Investigations · pp. 1-16 · 0 citations · 23 references
Medicine

TL;DR

It is demonstrated that cinnamaldehyde protects against LPS-induced acute lung injury by suppressing excessive NET formation, highlighting NET inhibition as a key mechanism underlying its pulmonary protective effects.

Abstract

Background

Excessive neutrophil activation and neutrophil extracellular trap (NET) formation play critical roles in the pathogenesis of acute lung injury (ALI). Cinnamaldehyde, a major bioactive component of cinnamon, has been reported to exert anti-inflammatory effects; however, its impact on NET formation in ALI remains unclear.

Methods

A lipopolysaccharide (LPS)-induced ALI rat model and a PMA-stimulated primary neutrophil model were employed to evaluate the effects of cinnamaldehyde in vivo and in vitro. Lung injury severity, pulmonary edema, inflammatory cell infiltration, cytokine production, and NET-associated markers were assessed using histopathology, wet-to-dry ratio analysis, BALF examination, immunofluorescence staining, and Western blotting.

Results

Cinnamaldehyde significantly alleviated LPS-induced lung injury, as evidenced by reduced lung wet-to-dry ratios and improved histopathological scores compared with the LPS group (p < .001). Treatment with cinnamaldehyde markedly decreased inflammatory cell and neutrophil infiltration in BALF and suppressed TNF-α, IL-6, and MCP-1 levels (p < .05-0.001). Furthermore, cinnamaldehyde significantly inhibited NET formation in lung tissues, as indicated by reduced levels of myeloperoxidase, cell-free DNA, citrullinated histone H3, and neutrophil elastase (p < .001). In vitro, cinnamaldehyde directly suppressed PMA-induced NET release from primary neutrophils without affecting cell viability (p < .001).

Conclusion

These findings demonstrate that cinnamaldehyde protects against LPS-induced acute lung injury by suppressing excessive NET formation, highlighting NET inhibition as a key mechanism underlying its pulmonary protective effects.

View source

Similar papers

Sep 2026

Kumatakenin alleviates LPS-induced acute lung injury by attenuating pulmonary oxidative stress and neutrophil extracellular trap formation through CMA-associated regulation of PRL2.

Acute lung injury (ALI) is a life-threatening inflammatory syndrome with limited pharmacological treatment options. Kumatakenin, a plant-derived flavonoid with recognized anti-inflammatory potential, has not been explored in inflammatory lung injury. Here, we investigated the protective effect of Kumatakenin in lipopol...

Dongmei Hai, Xiao-Yun Zhu, Sai-Ya Ye et al. · 0 citations
Open access Oct 2026

Shengjiang San suppresses C5a/C5aR1-mediated neutrophil activation and NET formation to alleviate acute lung injury

SJS attenuated LPS-induced ALI and restrained neutrophil activation and NET formation mediated by C5a/C5aR1 signaling, and Ferulic acid was identified as a candidate circulating constituent that reduced C5a-activated NET formation.

Dan Zhang, Xin-Xin Li, Jia Zeng et al. · 0 citations
Open access Oct 2026

HSPA12B modulates lung injury and neutrophil-related inflammatory responses in LPS-induced acute lung injury: a potential link to the PKC-PAD4 pathway.

Acute lung injury (ALI) and acute respiratory distress syndrome (ARDS) are life-threatening conditions with high mortality. Excessive neutrophil activation and neutrophil extracellular trap (NET)-related responses, together with pulmonary endothelial barrier impairment, are critical pathological features. Heat shock pr...

Wei-Fang Wu, Yu-Shan Lin, Yi-Ze Bian et al. · 0 citations
Open access Oct 2026

CC16 Ameliorates Inflammatory Responses and Acute Lung Injury in Mice by Modulating NF-κB/MAPK Signaling

Background: Acute lung injury (ALI) is a severe inflammatory lung condition characterized by alveolar damage, barrier disruption, and excessive inflammation. Current therapeutic strategies remain limited, highlighting the need for novel therapeutic targets. Dysregulated nuclear factor kappa B (NF-κB) and mitogen-activa...

Zhou Wang, Qi-Qi Xie, An-Quan Wang · 0 citations
Sep 2026

Dezocine mitigates LPS-induced acute lung injury by regulating alveolar macrophage polarization.

Acute lung injury (ALI) or its more severe form, acute respiratory distress syndrome, is a life-threatening disease closely associated with an imbalance of M1/M2 macrophage polarization. Dezocine is commonly used clinically for perioperative pain relief, but whether it can regulate lipopolysaccharide (LPS)-induced alve...

Zhen-Zhen Liu, Man Feng, Zi-Qiang Qiu et al. · 0 citations
Sep 2026

Ginsenoside alleviates sepsis related acute lung injury by inhibiting the destruction of alveolar epithelial barrier mediated by EVs secreted by alveolar macrophages.

Sepsis-associated acute lung injury (SALI) is a critical complication of sepsis, characterized by alveolar epithelial barrier disruption and excessive inflammation, which contributes substantially to morbidity and mortality. The present study investigates the protective effects of ginsenoside Rb1 on SALI and elucidates...

Ming Hao, Yun-Yan Zhang, Liu Chen et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.